Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021)

Yükleniyor...
Küçük Resim

Tarih

2022

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Polish Academy of Sciences

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

We published the abovementioned article about probiotic mixture VSL#3 on October 6, 2021. Since the product was named VSL#3 in our purchasing process in early 2016, it is referred to as VSL#3 in our article. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome® in the United States and Vivomixx® in Europe. The authors would like to apologise for any inconvenience caused.

Açıklama

Anahtar Kelimeler

Omega-3, VSL#3, Fatty Acids, DNBS-Induced Colitis

Kaynak

Folia Biologica-Krakow

WoS Q Değeri

Q4

Scopus Q Değeri

N/A

Cilt

70

Sayı

1

Künye

Yoldaş İlktaç, H., Kızıltan, G., Devrim Lanpir, A., Ozansoy, M., Günal, M. Y., Özmen Toğay, S. ... Kılıç, Ü. (2022). Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021). Folia Biologica-Krakow, 70(1), 43-43. https://doi.org/10.3409/fb_70-1.05